top of page
The Cooper Companies, Inc. (NASDAQ: COO) Reports Strong Q1 Earnings and Revenue Growth

The Cooper Companies, Inc. (NASDAQ: COO) Reports Strong Q1 Earnings and Revenue Growth

  • The Cooper Companies, Inc. (NASDAQ: COO) exceeded analyst expectations with a non-GAAP earnings per share (EPS) of $1.21, significantly above the $1.13 estimate.
  • Quarterly revenue reached $1.08 billion, surpassing the $1.06 billion consensus and marking an 8% year-over-year increase.
  • The company demonstrates consistent operational strength, marking its fourth consecutive quarter of surpassing EPS estimates and tenth straight quarter of exceeding consensus earnings, highlighting robust stock performance.

The Cooper Companies, Inc. (NASDAQ: COO) is a global medical device company. It operates through two main business units: CooperVision, which provides contact lenses, and CooperSurgical, which offers medical devices and fertility products for women's health. The company focuses on developing and manufacturing advanced healthcare products for a worldwide market.

The company's latest financial results show a non-GAAP earnings per share (EPS) of $1.21, which is above analyst estimates of $1.13. This non-GAAP figure excludes one-time costs, like a litigation charge, to show ongoing business performance. This result is a 26% increase from the $0.96 per share reported a year ago, showcasing strong financial performance.

Revenue for the quarter is $1.08 billion, exceeding the consensus estimate of $1.06 billion. As announced by GlobeNewswire, this marks an 8% increase from the prior year's quarter. This revenue growth indicates strong and consistent demand for The Cooper Companies, Inc.'s medical devices and services across its divisions.

This report continues a strong pattern for The Cooper Companies, Inc. As highlighted by Zacks, this is the fourth consecutive quarter that the company surpasses consensus EPS estimates. The company's CEO notes this is the tenth straight quarter of exceeding consensus earnings, showing consistent operational success and positive investment analysis.

The company's financial health appears solid, with a Debt-to-Equity ratio of 0.30. This ratio suggests the company relies more on owner's funds than borrowed money. Its Price-to-Earnings (P/E) ratio is 55.69, indicating how much investors are currently willing to pay for each dollar of earnings, providing key insights into its investment valuation.

Want to know when to buy this stock? Download the Stocks 2 Buy app or try the Web version

Group 82_edited.png

Forecast your chosen stock price with the Stock Sentiment Map

Comments

Share Your ThoughtsBe the first to write a comment.
Copy of Logo circular simple negro.png
bottom of page